DE307858C - - Google Patents
Info
- Publication number
- DE307858C DE307858C DENDAT307858D DE307858DA DE307858C DE 307858 C DE307858 C DE 307858C DE NDAT307858 D DENDAT307858 D DE NDAT307858D DE 307858D A DE307858D A DE 307858DA DE 307858 C DE307858 C DE 307858C
- Authority
- DE
- Germany
- Prior art keywords
- mercury
- chloride
- water
- cystine
- cysteine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine zwitterion Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 16
- 229960003067 Cystine Drugs 0.000 claims description 15
- 235000018417 cysteine Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- NZXPTVYDWSCLNC-UHFFFAOYSA-L [Hg+].[Cl-].[Na+].[Cl-] Chemical compound [Hg+].[Cl-].[Na+].[Cl-] NZXPTVYDWSCLNC-UHFFFAOYSA-L 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 claims description 5
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M Lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M Sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 235000019441 ethanol Nutrition 0.000 claims description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 3
- 229910052753 mercury Inorganic materials 0.000 claims description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 2
- 229940075581 sodium bromide Drugs 0.000 claims description 2
- -1 Mercury - Sodium Chemical compound 0.000 claims 3
- UKWHYYKOEPRTIC-UHFFFAOYSA-N Mercury(II) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 claims 2
- 229910000474 mercury oxide Inorganic materials 0.000 claims 2
- XVOYSCVBGLVSOL-UHFFFAOYSA-N Cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 claims 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M Sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 claims 1
- LGVIKZSMTRUKLL-UHFFFAOYSA-L [Cl-].[Li+].[Hg]Cl Chemical compound [Cl-].[Li+].[Hg]Cl LGVIKZSMTRUKLL-UHFFFAOYSA-L 0.000 claims 1
- DOBZZOPBAIMPRH-UHFFFAOYSA-L [Na+].[Cl-].[Cl-].[Ag+] Chemical compound [Na+].[Cl-].[Cl-].[Ag+] DOBZZOPBAIMPRH-UHFFFAOYSA-L 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000000249 desinfective Effects 0.000 description 6
- 239000000645 desinfectant Substances 0.000 description 4
- 210000004185 Liver Anatomy 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- KOAZNIJQXKRVKQ-UHFFFAOYSA-L [Br-].[Na+].[Hg+].[Br-] Chemical compound [Br-].[Na+].[Hg+].[Br-] KOAZNIJQXKRVKQ-UHFFFAOYSA-L 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 230000002070 germicidal Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
Description
KAISERLICHESIMPERIAL
PATENTAMT;/PATENT OFFICE; /
PATENTSCHRIFTPATENT LETTERING
; KLASSE \2g. GRUPPE ; CLASS \ 2g. GROUP
Die Auffindung von Heilmitteln zur Bekämpfung des Typhus und anderer Infektionskrankheiten, die in der Leber ihren Ursprung haben, ist gerade in der gegenwärtigen Zeit ein Problem, mit dem sich viele Forscher beschäftigen. Bis jetzt ist es aber noch nicht gelungen, der Lösung dieses Problems näher zu. kommen. Eine wirksame Bekämpfung dieser Krankheiten erscheint nur dann gewährleistet, wenn es gelingt, Heilmittel zu finden, die entweder durch Injektion oder durch innere Gaben in den Körper gebracht, in der Leber ihre desinfizierende Kraft zur vollen Entfaltung bringen können. Als solche können nur mit Desinfizientien gekuppelte Substanzen in Frage kommen, die eine Affinität zur Leber haben und dort so abgebaut werden, daß die Desinfizientien in Freiheit gesetzt werden und ihre keimtötende Wirkung entfalten können. Es wurde nun gefunden, daß Cystin und seine Derivate ausgezeichnete Desinfizientienträger darstellen. Die Verbindungen von Cystin und dessen Derivaten mit den Desinfizientien Quecksilber/ Quecksilberchlorid und SiI-ber sind aber, wegen ihrer Unlöslichkeit für Injektionszwecke nicht verwendungsfähig und auch innerlich gegeben weniger wirksam.Finding remedies to combat it Typhoid and other infectious diseases that originate in the liver are just in the present day a problem that many researchers are concerned with. But it's not up to now managed to get closer to solving this problem. come. An effective fight of these diseases only appears guaranteed if it is possible to find remedies, which are brought into the body either by injection or by internal gifts, in the Liver to full its disinfecting power Can bring development. As such, only substances coupled with disinfectants can be used come into question that have an affinity for the liver and are broken down there in such a way that the disinfectants are set free and can develop their germicidal effect. It has now been found that cystine and its derivatives are excellent disinfectant carriers represent. The compounds of cystine and its derivatives with disinfectants Mercury / mercury chloride and SiI-ber however, because of their insolubility for injection purposes, they cannot be used and also less effective internally.
Es wurde nun weiter gefunden, daß man leicht lösliche und äußerst wirksame Doppelsalze, sowohl für innerliche Gaben als auch für Injektionszwecke geeignet, -erhält, wenn man Cystin- und Cysteinquecksilber, Cystin- und Cysteinquecksilberchlorid sowie Cystinsilber, und Cysteinsilber (vgl. Zeitschrift für physiologische Chemie, Bd. 44, S. 472 ff.; Hofmeister, Bd. 3, S. ι ff.; Biochemisches Hand- ! lexikon Abderhalden, Bd. 4, S. 658 ff.) oder andere mit vorgenannten Desinfizientien gekuppelte Cystinderivate in wenig überschüssiger gesättigter Kochsalzlösung oder in entsprechenden gesättigten Lösungen von Natriumbromid, Natriumrhodanat und Lithiumchlorid löst, die erhaltene Lösung mit Aceton, Äthylalkohol, Methylalkohol oder Äther im Überschuß versetzt und den entstandenen Niederschlag ab- 4S saugt.It has now also been found that easily soluble and extremely effective double salts, suitable both for internal administration and for injection purposes, are obtained when cystine and cysteine mercury, cystine and cysteine mercury chloride as well as cystine silver and cysteine silver (cf. Zeitschrift für Physiologische Chemie, Vol. 44, p. 472 ff .; Hofmeister, Vol. 3, p. Ι ff .; Biochemisches Hand- ! Lexikon Abderhalden, Vol. 4, p. 658 ff.) Or other cystine derivatives coupled with the aforementioned disinfectants in little excess saturated saline or dissolved in the corresponding saturated solutions of sodium bromide, and lithium chloride Natriumrhodanat, the resulting solution with acetone, ethyl alcohol, methyl alcohol or ether was added in excess and the resulting precipitate is suctioned off 4S.
Die so erhaltenen Produkte stellen komplexe Salze mit amphoterer Reaktion dar. 1The products thus obtained are complex salts with an amphoteric reaction. 1
1. Cystinquecksilber-Natriumchlorid; Cystinquecksilber wird in gesättigter (33 prozentiger) Kochsalzlösung vollkommen gelöst, wobei ein größerer Überschuß des Lösungsmittels zu vermeiden ist. Die Lösung wird mit reinstem Aceton oder einem der oben erwähnten Fällungsmittel im Überschuß versetzt und gut durchgeschüttelt. Der entstandene Niederschlag der komplexen Kochsalz-Cystinquecksilberverbindung wird rasch abgenutscht, mit Alkohol und Äther gewaschen und im Vakuum getrocknet. r1. cystine mercury sodium chloride; Cystine mercury is completely dissolved in saturated (33 percent) saline solution, whereby a larger excess of the solvent is to be avoided. The solution is made with the purest Acetone or one of the above-mentioned precipitants added in excess and good shaken. The resulting precipitate of the complex common salt-cystine mercury compound is quickly sucked off, washed with alcohol and ether and in a vacuum dried. r
Cystinquecksilber-Natriumchlprid ist ein gelbes Pulver, das sich in Wasser klar mit braungelber Farbe löst. ■■ . Cystine Mercury Sodium Chloride is a yellow one Powder that dissolves clear with a brownish yellow color in water. ■■.
Die in nachfolgenden Beispielen 2 bis 5 beschriebenen Doppelsalze werden in derselben Weise wie Cystinquecksilber-Natriumchlorid dargestellt. 1 'The double salts described in Examples 2 to 5 below are used in the same Way represented as cystine mercury sodium chloride. 1 '
2. Cystinquecksilber-Natriumbromid ist ein braunes Pulver, das sich in Wasser klar mit, brauner Farbe löst.2. Cystine mercury sodium bromide is a brown powder that becomes clear in water with, brown color dissolves.
Claims (1)
Publications (1)
Publication Number | Publication Date |
---|---|
DE307858C true DE307858C (en) |
Family
ID=561161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT307858D Active DE307858C (en) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE307858C (en) |
-
0
- DE DENDAT307858D patent/DE307858C/de active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE307858C (en) | ||
DE2232988A1 (en) | FILARICIDE AND TRYPANOCIDE PHENYLARSENDITHIO COMPOUNDS | |
DE895769C (en) | Process for the preparation of inclusion compounds of physiologically active organic compounds | |
DE938502C (en) | Method of making a colloidal iron preparation | |
AT77319B (en) | Process for the preparation of water-soluble compounds of cystine and its derivatives with disinfectants for combating typhoid and other infectious diseases which have their origin in the liver. | |
DE255030C (en) | ||
DE2357864A1 (en) | Anti-diabetic agents prepn. - from biguanidine (salt) and nicotinic acid (salt) | |
DE322996C (en) | Process for the preparation of easily and clearly soluble nucleic acid compounds of yohimbine | |
DE605074C (en) | Process for the preparation of compounds of sulfhydryl keratinic acid and similar reduced degradation products of keratin with organic compounds containing arsenic | |
DE2820992A1 (en) | MEDICINAL PRODUCTS BASED ON NITROIMIDAZOLE | |
DE3535355A1 (en) | Water-soluble pharamceutical compositions based on salts of (-)-cis-1,2-epoxypropylphosphonic acid with amino acids | |
DE416327C (en) | Process for the preparation of sodium tribismutyl tartrate | |
DE216267C (en) | ||
DE839802C (en) | Process for the preparation of salts of heparic acid | |
DE597414C (en) | Process for the production of soluble derivatives of polyaminoarsenostibio compounds | |
DE399904C (en) | Process for the production of organic mercury compounds | |
AT103978B (en) | Process for the preparation of new arsenic compounds from china bases | |
DE540700C (en) | Process for the preparation of an organic arsenic compound of the pyrazolone series | |
DE221483C (en) | ||
DE558752C (en) | Process for the production of neutral complex antimony salts | |
DE279957C (en) | ||
DE667845C (en) | Process for the preparation of symmetrical dioxalkylated aminoarsenobenzenes | |
DE261229C (en) | ||
DE1493973C (en) | Square brackets on 2- (substituted-mercapto-methyl) -acyl square brackets on phenoxyacetic acids and their salts, processes for their production and pharmaceuticals containing these compounds | |
DE519531C (en) | Process for the production of an easily water-soluble, colloidal silver-tannin-protein compound |